University of Thessaly (UTH)
Διερεύνηση της επίδρασης παραγόντων ειδικών του φύλου στην in vivo δραστικότητα του μεταβολικού ενζύμου CYP1A2
Abstract
dc:descriptionCYP1A2 activity is reduced by the presence of sex hormones such as the use of oral contraceptives, hormone replacement therapy and pregnancy. The purpose of this study was to investigate the effect of fluctuations of hormones (mainly of estrogen) that occur during the normal menstrual cycle in the in vivo activity of the enzymes CYP1A2, CYP2A6, XO and NAT-2. Moreover, the distribution of the two most common single nucleotide polymorphisms of CYP1A2 gene (CYP1A2*1C and CYP1A2*1F) was studied in order to investigate the effect of genotype on the phenotypic expression of CYP1A2.Methods: The study was conducted in 42 healthy, premenopausal women (25 non-smokers, NS and 17 smokers, S). Urine and blood samples were collected during the early follicular phase (EFP), late follicular phase (LFP) and the luteal phase (LP). Levels of 17-beta estradiol, progesterone, FSH and LH were measured in the three phases of the cycle. The activity of the enzymes CYP1A2, CYP2A6, XO and NAT-2 was determined using the urinary caffeine metabolic ratios (AFMU+1U+1X)/17U, 17U/(17U+17X), 1U/(1X+1U), AFMU/(AFMU+1U+1X), respectively, in the three phases of the cycle using the RP-HPLC method. The genotype for polymorphisms -3860G>A (allele CYP1A2*1C) and -163C>A (allele CYP1A2*1F) was determined using the PCR-RFLP method.Results: The activity of CYP1A2 was reduced in the late follicular compared to the early follicular and luteal phase of both 25 non-smokers (EFP: 3,18 ± 1,00, LFP: 2.76 ± 0.77, LP 3.06 ± 0.84; p <0.05, RM ANOVA on Ranks) and 17 smokers (EFP: 5.20 ± 2.11, LFP: 4.41 ± 1.26, LF: 4.93 ± 1.49; p> 0.05, One Way RM ANOVA), although the difference was not statistically significant in smokers. CYP2A6 activity was found to be higher in the late follicular phase (0.70 ± 0.13) and differed from the early follicular (0.60 ± 0.12; p <0,05), but not from the luteal phase (0.63 ± 0.13; p> 0.05, RM ANOVA on Ranks). No statistically significant difference was detected in XO activity (EFP: 0.52 ± 0.06, LFP: 0.52 ± 0.05, LP: 0.51 ± 0.05; p> 0.05, One Way RM ANOVA) and NAT-2 fast acetylators activity (EFP: 0.36 ± 0.05, LFP: 0.38 ± 0.06, LP: 0.36 ± 0.04; p> 0.05, One Way RM ANOVA) between the three phases of the cycle. NAT-2 slow acetylators activity was found to be higher in the late follicular phase (0.09 ± 0.02) compared to the early follicular (0.07 ± 0.02) and the luteal phase (0.07 ± 0.02; p <0.05, One Way RM ANOVA). In the study only the polymorphism CYP1A2*1F was detected. Smokers with genotype A/A had significantly higher mean caffeine metabolic ratios (5.71 ± 1.69) compared to the A/C carriers (4.32 ± 1.63; p <0.05, Mann-Whitney test), while this difference was not observed in non-smokers (A/C: 3.35 ± 1.22, A/A: 3.09 ± 0.52; p> 0.05, Mann-Whitney test). The genotype was found not to affect the activity of CYP1A2 in the three phases of the cycle (p> 0.05, Repeated Measures General Linear Model).Conclusion: This study showed: 1) reduction of CYP1A2 activity, 2) increase of CYP2A6 activity, and 3) increase of NAT-2 slow acetylators activity, in the late follicular phase, where estrogen are at the highest levels. The activity of XO and NAT-2 fast acetylators did not differ in the various phases of the cycle. Normal fluctuations in estrogen during the phases of the normal menstrual cycles may be associated with variation in the CYP1A2, CYP2A6 and NAT-2 slow acetylators activity.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- tsiokou, vasiliki
- Τσιώκου, Βασιλική
Subjects
dc:subject × 5Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37079